Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Investment Group Regulatory News (IIG)

Share Price Information for Intuitive Investment Group (IIG)

Share Price is delayed by 15 minutes
Get Live Data
234.00    8.00 (3.45%)
Bid:
228.00
Ask:
240.00
Spread: 12.00 (5.263%)
Market Cap: £574.33m
IIG Live PriceLast checked at - London Stock Exchange

Intraday Intuitive Investment Group Share Chart

Subscription

2 Mar 2022 07:00

RNS Number : 2620D
Intuitive Investments Group plc
02 March 2022
Β 

Β 

Intuitive Investments Group plc

Β 

Subscription to raise Β£607,000 at 22p including Directors' participation of Β£432,000

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, further to the announcement of 25 February 2022, announces the completion of the subscription of new ordinary shares of 1 penny each in the share capital of the Company ("Ordinary Shares").

The Company has raised Β£607,000 by the issue of 2,759,091 new Ordinary Shares (the "Subscription Shares") at a price of 22 pence per Subscription Share (the "Subscription").

The subscription price of 22 pence represents a premium of 33.3% to the closing mid-market price of 16.5 pence per Ordinary Share on 24 February 2022, being the date before the announcement of, amongst other things, the Subscription.

Directors' participation

The Subscription includes the participation of certain of IIG's Directors and David Evans who have subscribed in aggregate for 1,963,635 Subscription Shares, raising Β£432,000 of the Β£607,000 gross proceeds of the Subscription as summarised below.

Β 

Participating Director*

Number of Existing Ordinary Shares

Amount subscribed in the Subscription

Number of Subscription Shares subscribed for

Number of Ordinary Shares following the Subscription

Percentage of IIG's share capital enlarged by the Subscription and First Tranche Consideration Shares

Julian Baines (Chairman)

22,624

Β£50,000

227,272

249,896

0.38%

David Evans

5,000,000

Β£132,000

600,000

5,600,000

8.51%

Robert Naylor (CEO)

1,250,000

Β£250,000

1,136,363

2,386,363

3.63%

Β 

Admission and Total Voting Rights

Application has been made for the admission ofΒ Subscription Shares to trading on AIM and dealings are expected to commence at 8.00 a.m. on or around 4 March 2021.

Immediately following the admission of the Subscription Shares and the 22,589,352 First Tranche Consideration Shares (the "Admission"), the Company's enlarged share capital will compriseΒ 65,790,267Β Ordinary Shares.

Each Ordinary Share has one voting right and no Ordinary Shares are held in treasury. Accordingly, immediately following Admission, the total number of voting rights will beΒ 65,790,267. From Admission, this figure may be used by Shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Defined terms used in this Announcement carry the same meanings as those ascribed to them in the Company's Announcement of 25 February 2022, unless the context requires otherwise.Β 

Β 

For further information, please contact:

Β Intuitive Investments Group plc

www.iigplc.com

Julian Baines, Non-Executive Chairman

Robert Naylor, CEO

Via Walbrook PR

Β 

Β 

SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0) 20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

Β 

Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope

Β 

Β 

Β 

Walbrook PR Limited - Media & Investor Relations

+44 (0)20 7933 8780 orΒ intuitive@walbrookpr.com

Paul McManus/ Sam Allen

+44 (0) 7980 541 893 / +44 (0) 7502 558 258

Β 

About Intuitive Investments Group plc

The Company is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders.

Β 

Dealings by Persons Discharging Managerial Responsibilities

Β 1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

1) Julian Baines

2) David Evans

3) Robert Naylor

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

1) Chairman

2) Chair of the Investment Committee

3) CEO

Β 

b)

Β 

Initial notification /Amendment

Β Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β Intuitive Investments Group plc

b)

Β 

LEI

Β 

2138004A32UIY92WWR66

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

ordinary shares of 1p each

Identification code

ISIN: GB00BNGFMW59

b)

Β 

Nature of the transaction

Β 

Participation in Placing

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

1.

Price(s)

Volume(s)

22.0 pence

227,272

Β 

2.

Price(s)

Volume(s)

22.0 pence

600,000

Β 

3.

Price(s)

Volume(s)

22.0 pence

1,136,363

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

d)

Β 

Aggregated information

- Aggregated volume

1,963,635

- Price

22.0 pence

e)

Β 

Date of the transactions

28 February 2022

f)

Β 

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEBKDBPPBKDCNK
Date   Source Headline
28th Feb 20247:00 amRNSIssue of shares
27th Feb 20247:00 amRNSHui10 approved to expand with China Sports Lottery
16th Feb 20247:00 amRNSAppointment of Corporate Broker
6th Feb 202410:45 amRNSPosting of Annual Report and AGM Notice
1st Feb 20242:23 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSFinancial Results
4th Jan 20242:54 pmRNSIssue of shares
29th Dec 20237:00 amRNSTotal Voting Rights
12th Dec 20233:48 pmRNSIssue of shares
28th Nov 20237:00 amRNSUpdate to the Board of Directors
3rd Nov 20231:36 pmRNSDirector Dealing
1st Nov 202310:41 amRNSHolding(s) in Company
27th Oct 20231:33 pmRNSDirector Dealing
27th Oct 20237:00 amRNSInvestment in Hui10 Inc
31st Aug 20238:25 amRNSTotal Voting Rights
10th Aug 202311:08 amRNSHolding(s) in Company
8th Aug 20238:00 amRNSReadmission - Intuitive Investments Group plc
28th Jul 20233:35 pmRNSGM, Tender Offer & Placing & Directorate Change
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
11th Jul 202310:47 amRNSNotice of General Meeting - Correction
11th Jul 20237:00 amRNSNotice of General Meeting to approve Proposals
11th Jul 20237:00 amRNSIIG appoints Sir Nigel Rudd as its next Chairman
5th Jul 20233:46 pmRNSFORM 8.3 - Yourgene Health Plc
29th Jun 20237:00 amRNSInterim report for the six months to 31 March 2023
31st May 20237:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSReorganisation and Deferred Consideration
26th Apr 20234:57 pmRNSHolding(s) in Company
17th Jan 202311:19 amRNSResult of AGM and Directorate Change
11th Jan 202310:00 amRNSInvestment in Yourgene Health plc
21st Dec 20227:00 amRNSFinal Results
7th Nov 20222:05 pmRNSSecond Price Monitoring Extn
7th Nov 20222:00 pmRNSPrice Monitoring Extension
5th Aug 20227:00 amRNSInvestment in PneumoWave Limited
26th May 20227:00 amRNSUpdate on Sanondaf
25th May 20227:00 amRNSHalf-year Report
20th Apr 202211:13 amRNSDispensation from Rule 9 of the Code
4th Apr 202211:13 amRNSTotal Voting Rights
8th Mar 20223:39 pmRNSHolding(s) in Company
2nd Mar 20227:00 amRNSSubscription
25th Feb 202212:11 pmRNSInvestment & Appointment of Non-Executive Chair
14th Feb 202212:59 pmRNSChange of Registered Office
14th Feb 20227:00 amRNSInvestment in Ocutec Limited
24th Jan 20228:45 amRNSDirector Dealing
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office
6th Dec 20217:00 amRNSFinal Results and Notice of AGM
29th Nov 20217:00 amRNSChange of Adviser
5th Nov 202110:12 amRNSHolding(s) in Company
28th Oct 20211:38 pmRNSNotice of Results
15th Oct 20218:01 amRNSLight Science Technologies Holdings - Floatation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.